Stockbuphoon
The companies that know the clinical data on the 4050 pbi indications that almost made a supposed deal with Pierre could buy Liminal for next to nothing getting their cash and small molecule assets. That would be extremely cheap and probably the best steal ever. That is if the Alstom trial was legit.